CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.
LATEST ALERTS
View all Cannabis and cannabinoids in Minnesota
Regulatory reports
Comprehensive legal reports outlining how the sector is regulated, interpretation of the laws and relevant bodies
Regulatory databases
Regularly updated global regulations currently in place, compiled into easy-to-read maps and tables
New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
Daily news alerts
Our legal experts track the evolving regulation around the cannabinoid and cannabis sector on a daily basis. These alerts are then compiled into our Round-up section.
9th January 2023
US - Minnesota: Democrats in the Minnesota state legislature have vowed to pass a bill to legalise recreational cannabis in 2023, press reports. Democrats have just taken control of the Senate and now control both chambers of the legislature and the governorship. Governor Tim Walz has voiced support for legalising, so there appears to be the necessary political support to pass legislation. House File (HF) 100 has been introduced and currently has 19 sponsors.7th December 2022
US - Minnesota: State regulators are suing a producer of cannabis products for allegedly violating Minnesota’s maximum level of THC that edible products can contain. Under a new state law, hemp-derived edible products may contain up to 5 mg of THC per serving and 50 mg per package; Northland Vapor’s edible products allegedly contained up to 100 mg per serving and 2,500 mg per package. A joint investigation into the products was conducted by the Minnesota Board of Pharmacy and the US Food and Drug Administration (FDA).
11th November 2022
- US - Minnesota: Governor Tim Waltz told former governor Jesse Ventura that legalising recreational cannabis will be "one of the first" things passed by the incoming legislature, and even invited Ventura to the signing of the bill to legalise, press reports. Legalisation appears more likely now that the Democrats have taken over the state Senate as a result of Tuesday's midterm elections, giving them control of both chambers of the legislature and the governor's office. A bill to legalise recreational cannabis was passed in May by the Democrat-controlled House but was rejected by the then-Republican-controlled Senate.
22nd September 2022
US - Minnesota: Medical cannabis company Vireo Health has filed a lawsuit against the state alleging that House File (HF) 4065 – which allows the sale of hemp-derived edibles – unfairly discriminates against cannabis-derived edibles. According to the company, the hemp-derived edibles are chemically identical to their cannabis-derived medical edibles.
30th June 2022
- US - North Carolina: With North Carolina’s hemp statute set to expire after today, 30th June, the state Senate concurred in amendments to Senate Bill (SB) 455, which will keep hemp and its products legal in the state on a permanent basis if signed by the governor. SB 455 would essentially maintain the status quo for hemp products in North Carolina, but it includes a minor yet significant addition. Previously, hemp was excluded from the definition of marijuana in the controlled substances list but not from the definition of tetrahydrocannabinols (THC). A similar situation in Minnesota caused a court to call into question the legality of full-spectrum hemp products. However, SB 455 would resolve the issue by excluding hemp from the definition of THC. Doing so also likely clarifies any doubts about the legality of hemp-derived delta-8 THC products in the state.
22nd June 2022
- US - Federal: The US Supreme Court has denied taking up a pair of cases to resolve the issue of whether federal workers’ compensation must cover the cost of medical cannabis when workers are injured on the job, press reports. The Minnesota Supreme Court earlier ruled that the federal prohibition on cannabis pre-empted state law, so employers were not required to cover the costs for medical cannabis. The US Department of Justice had asked the court not to review the cases, as it opined that federal cannabis policy is best left to Congress and the executive branch.
3rd June 2022
- US - Minnesota: House File (HF) 4065 has been signed into law by the governor. The new law prohibits the sale of hemp-derived cannabinoid products (including CBD) to anyone under the age of 21 but explicitly allows hemp-derived edible cannabinoid products if certain testing and labelling requirements are met. Additionally, HF 4065 caps the amount of any THC in edible products at 5 mg per serving and 50 mg per package. It effectively bans vape products with more than 0.3% of any THC (including delta-8) but would still allow delta-8 products in edible form within the THC cap.
25th May 2022
US - Minnesota: House File 3595 was passed by the legislature as an amendment to HF 4065 and now heads to the governor for final approval. The bill would prohibit the sale of hemp-derived cannabinoid products (including CBD) to under-21s but would explicitly allow hemp-derived edible cannabinoid products if certain testing and labeling requirements are met. It would also cap the amount of any THC in edible products at 5 mg per serving and 50 mg per package. HF 3595 would effectively ban vape products with more than 0.3% of THC (including delta-8) but would still allow delta-8 products in edible form within the THC cap.
21st March 2022
US - Minnesota: The Minnesota Board of Pharmacy voted to remove THC contained in hemp products (up to 0.3%) from the state’s controlled substances list, local media reports. The vote provides some clarity for selling hemp-derived products after a court of appeals decision that threw into question the legality of hemp-derived products containing any amount of THC.
2nd March 2022
- US - Minnesota: The Minnesota Department of Health has published its final version of rules to regulate medical cannabis. The rules amend regulations pertaining to the packaging, labelling, testing, production, and distribution of medical cannabis.
